Comrade Applian. (543921)
TurnaroundScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹94 |
| Market Cap | ₹73.12 Cr |
| P/E Ratio | 0 |
| ROCE | 6.85% |
| ROE | —% |
| Dividend Yield | 0% |
| Profit Growth | -285.08% |
| Debt/Equity | — |
| Sales Growth | -11.66% |
| 52-Week Range | ₹28.56 — ₹111.27 |
| Sector | Consumer Durables |
Strengths
- ROCE is positive at 6.85% despite the net loss, suggesting some operating earnings before interest and tax.
- Latest quarter sales of ₹15 Cr provide a quarterly revenue base that could support a turnaround if costs are controlled.
- Market cap is small at ₹73 Cr, giving room for potential growth if the company finds a defensible niche.
- Price has recovered sharply from the 52-week low of ₹28.56, indicating some market interest.
Concerns
- Net loss of ₹7 Cr on quarterly sales of ₹15 Cr implies severely negative margins.
- Sales growth is -11.66% and profit growth is -285.08%, showing fundamental deterioration.
- Piotroski F-Score of 3/9 signals weak financial health and possible distress.
- Critical data—P/E, book value, debt/equity, promoter holding—are missing, preventing a proper margin-of-safety assessment.
AI Analysis
Looking at Comrade Applian, I see a business that fails Benjamin Graham's first test: it is losing money. The latest quarter shows sales of ₹15 Cr but a net loss of ₹7 Cr, and profit growth has collapsed by 285%. With a P/E of 0 and no book value available, the usual valuation yardsticks are useless. This is not an investment; it is a speculation. In consumer electronics, moats are rare—brands, scale, and distribution matter. A ₹73 Cr market cap player competing against larger Indian and global names has no obvious pricing power. Sales growth is -11.66%, meaning demand is shrinking. ROCE of 6.85% is too low to inspire confidence; I want high returns on tangible capital, not a figure that barely covers the cost of capital. The Piotroski F-Score of 3/9 adds another red flag: financial health looks weak. The dividend yield is zero, so there is no reward for waiting. At ₹94, the stock sits in a 52-week range of ₹28.56 to ₹112, but a falling knife does not become attractive simply because it bounced. Buffett would say it is far better to buy a wonderful company at a fair price than a weak company at a cheap price. This is a turnaround candidate only in the sense that it must first survive, then fix operations, then regain growth. I need proof: a few quarters of positive net profit, stabilising sales, and a believable path to higher ROCE. Until then, there is no margin of safety. As Graham said, the market votes with emotion, but I weigh with numbers—and these numbers show losses.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer